Related references
Note: Only part of the references are listed.Genome-Wide Association Study of Susceptibility to Idiopathic Pulmonary Fibrosis
Richard J. Allen et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)
Single-cell RNA-seq reveals ectopic and aberrant lung-resident cell populations in idiopathic pulmonary fibrosis
Taylor S. Adams et al.
SCIENCE ADVANCES (2020)
Single-cell RNA sequencing reveals profibrotic roles of distinct epithelial and mesenchymal lineages in pulmonary fibrosis
Arun C. Habermann et al.
SCIENCE ADVANCES (2020)
E3 Ubiquitin Ligases RNF20 and RNF40 Are Required for Double-Stranded Break (DSB) Repair: Evidence for Monoubiquitination of Histone H2B Lysine 120 as a Novel Axis of DSB Signaling and Repair
Clare C. So et al.
MOLECULAR AND CELLULAR BIOLOGY (2019)
Evolving insights into the cellular and molecular pathogenesis of fibrosis in systemic sclerosis
Benjamin Korman
TRANSLATIONAL RESEARCH (2019)
Systemic Sclerosis Pathogenesis and Emerging Therapies, beyond the Fibroblast
Andrea Sierra-Sepulveda et al.
BIOMED RESEARCH INTERNATIONAL (2019)
Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease
Oliver Distler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
The FMS-like tyrosine kinase-3 ligand/lung dendritic cell axis contributes to regulation of pulmonary fibrosis
Meritxell Tort Tarres et al.
THORAX (2019)
Comprehensive Integration of Single-Cell Data
Tim Stuart et al.
CELL (2019)
Proliferating SPP1/MERTK-expressing macrophages in idiopathic pulmonary fibrosis
Christina Morse et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Single-cell analysis reveals fibroblast heterogeneity and myofibroblasts in systemic sclerosis-associated interstitial lung disease
Eleanor Valenzi et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Shared and distinct mechanisms of fibrosis
Joerg H. W. Distler et al.
NATURE REVIEWS RHEUMATOLOGY (2019)
GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways
Elena Lopez-Isac et al.
NATURE COMMUNICATIONS (2019)
Single-Cell Transcriptomic Analysis of Human Lung Provides Insights into the Pathobiology of Pulmonary Fibrosis
Paul A. Reyfman et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Epithelial Injury and Dysfunction in the Pathogenesis of Idiopathic Pulmonary Fibrosis
Nichelle I. Winters et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2019)
Dimensionality reduction for visualizing single-cell data using UMAP
Etienne Becht et al.
NATURE BIOTECHNOLOGY (2019)
The Gene Ontology Resource: 20 years and still GOing strong
S. Carbon et al.
NUCLEIC ACIDS RESEARCH (2019)
Novel idiopathic pulmonary fibrosis susceptibility variants revealed by deep sequencing
Jose M. Lorenzo-Salazar et al.
ERJ OPEN RESEARCH (2019)
Repurposing of gamma interferon via inhalation delivery
Gerald C. Smaldone
ADVANCED DRUG DELIVERY REVIEWS (2018)
Prediction of progression of interstitial lung disease in patients with systemic sclerosis: the SPAR model
Wanlong Wu et al.
ANNALS OF THE RHEUMATIC DISEASES (2018)
Idiopathic pulmonary fibrosis: Epithelial-mesenchymal interactions and emerging therapeutic targets
Justin C. Hewlett et al.
MATRIX BIOLOGY (2018)
Matrix Stiffness: the Conductor of Organ Fibrosis
Alba Santos et al.
CURRENT RHEUMATOLOGY REPORTS (2018)
New insights into the genetics and epigenetics of systemic sclerosis
Chiara Angiolilli et al.
NATURE REVIEWS RHEUMATOLOGY (2018)
MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease
P. -A. Juge et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Ubiquitination and deubiquitination emerge as players in idiopathic pulmonary fibrosis pathogenesis and treatment
Shuang Li et al.
JCI INSIGHT (2018)
pDCs in lung and skin fibrosis in a bleomycin-induced model and patients with systemic sclerosis
Suzanne Kafaja et al.
JCI INSIGHT (2018)
Cadmium stimulates myofibroblast differentiation and mouse lung fibrosis
Xin Hu et al.
TOXICOLOGY (2017)
Innate Immunity in Systemic Sclerosis
Christopher Dowson et al.
CURRENT RHEUMATOLOGY REPORTS (2017)
Mycophenolate Mofetil Versus Placebo for Systemic Sclerosis-Related Interstitial Lung Disease An Analysis of Scleroderma Lung Studies I and II
Elizabeth R. Volkmann et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Association of MicroRNA-618 Expression With Altered Frequency and Activation of Plasmacytoid Dendritic Cells in Patients With Systemic Sclerosis
Marzia Rossato et al.
ARTHRITIS & RHEUMATOLOGY (2017)
The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis
Zana Brkic et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
A potential contribution of antimicrobial peptide LL-37 to tissue fibrosis and vasculopathy in systemic sclerosis
T. Takahashi et al.
BRITISH JOURNAL OF DERMATOLOGY (2016)
Ubiquitin E3 ligase FIEL1 regulates fibrotic lung injury through SUMO-E3 ligase PIAS4
Travis Lear et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Management of interstitial lung disease associated with connective tissue disease
Stephen C. Mathai et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Management of interstitial lung disease associated with connective tissue disease
Stephen C. Mathai et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
αvβ6 integrin is required for TGFβ1-mediated matrix metalloproteinase2 expression
Anindita Dutta et al.
BIOCHEMICAL JOURNAL (2015)
Highly Parallel Genome-wide Expression Profiling of Individual Cells Using Nanoliter Droplets
Evan Z. Macosko et al.
CELL (2015)
Spatial reconstruction of single-cell gene expression data
Rahul Satija et al.
NATURE BIOTECHNOLOGY (2015)
The multifaceted biology of plasmacytoid dendritic cells
Melissa Swiecki et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Cellular interactions in the pathogenesis of interstitial lung diseases
Gianluca Bagnato et al.
EUROPEAN RESPIRATORY REVIEW (2015)
Predictors of Mortality and Progression in Scleroderma-Associated Interstitial Lung Disease A Systematic Review
Tiffany A. Winstone et al.
CHEST (2014)
Autologous Hematopoietic Stem Cell Transplantation vs Intravenous Pulse Cyclophosphamide in Diffuse Cutaneous Systemic Sclerosis A Randomized Clinical Trial
Jacob M. van Laar et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Transforming growth factor β-at the centre of systemic sclerosis
Robert Lafyatis
NATURE REVIEWS RHEUMATOLOGY (2014)
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Luca Richeldi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Interstitial Lung Disease Associated With Systemic Sclerosis and Idiopathic Pulmonary Fibrosis How Similar and Distinct?
Erica L. Herzog et al.
ARTHRITIS & RHEUMATOLOGY (2014)
The Idiopathic Pulmonary Fibrosis Honeycomb Cyst Contains A Mucocilary Pseudostratified Epithelium
Max A. Seibold et al.
PLOS ONE (2013)
The MUC5B Variant Is Associated with Idiopathic Pulmonary Fibrosis but Not with Systemic Sclerosis Interstitial Lung Disease in the European Caucasian Population
Raphael Borie et al.
PLOS ONE (2013)
The role of type 1 interferon in systemic sclerosis
Minghua Wu et al.
FRONTIERS IN IMMUNOLOGY (2013)
Delivery and Safety of Inhaled Interferon-γ in Idiopathic Pulmonary Fibrosis
Keith T. Diaz et al.
JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY (2012)
Prednisone, Azathioprine, and N-Acetylcysteine for Pulmonary Fibrosis
Ganesh Raghu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Lung Tissues in Patients With Systemic Sclerosis Have Gene Expression Patterns Unique to Pulmonary Fibrosis and Pulmonary Hypertension
Eileen Hsu et al.
ARTHRITIS AND RHEUMATISM (2011)
Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): an open-label, randomised phase 2 trial
Richard K. Burt et al.
LANCET (2011)
THE UNFOLDED PROTEIN RESPONSE: INTEGRATING STRESS SIGNALS THROUGH THE STRESS SENSOR IRE1α
Claudio Hetz et al.
PHYSIOLOGICAL REVIEWS (2011)
Effect and Safety of Mycophenolate Mofetil in Idiopathic Pulmonary Fibrosis
Argyris Tzouvelekis et al.
PULMONARY MEDICINE (2011)
Feedback amplification of fibrosis through matrix stiffening and COX-2 suppression
Fei Liu et al.
JOURNAL OF CELL BIOLOGY (2010)
Treatment of Scleroderma-Interstitial Lung Disease With Cyclophosphamide Is Associated With Less Progressive Fibrosis on Serial Thoracic High-Resolution CT Scan Than Placebo Findings From the Scleroderma Lung Study
Jonathan Goldin et al.
CHEST (2009)
Increased Bronchoalveolar Lavage Fluid CD1c Expressing Dendritic Cells in Idiopathic Pulmonary Fibrosis
M. Tsoumakidou et al.
RESPIRATION (2009)
Changes in causes of death in systemic sclerosis, 1972-2002
Virginia D. Steen et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia
Y Kondoh et al.
EUROPEAN RESPIRATORY JOURNAL (2005)
Open source clustering software
MJL de Hoon et al.
BIOINFORMATICS (2004)
Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome
D Bouros et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)